LY2189265 (Type 2 Diabetes) Analysis and Forecasts to 2020

GlobalDatas pharmaceuticals report, LY2189265 (Type 2 Diabetes) Analysis and Forecasts to 2020 provides LY2189265 sales estimates for US, EU5 and Japan. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2014-2020). The report also includes information on Type 2 Diabetes market. This report is built using data and information sourced from GlobalDatas proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by GlobalData's team of industry experts.

Scope

Therapy area profile including patient population for the US, EU5 and Japan (seven major markets)

Analysis and review of LY2189265 including historical sales data

Qualitative and quantitative assessment of market space

Analysis of the trends, drivers and restraints shaping and defining the markets

In-depth analysis of LY2189265 including efficacy, safety, pricing, competition and other details which influence its sales potential

Detailed sales forecast for 2014-2020 for LY2189265 in each of the seven major markets

Reasons to buy

Understand and capitalize by identifying products that are most likely to ensure a robust return

Stay ahead of competition by understanding the changing competitive landscape

Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential

Make more informed business decisions from insightful and in-depth analysis of the drugs performance

Examine the historical sales performance of a drug in seven major markets

Obtain sales forecast for currently marketed/pipeline drug for 2011-2020 for all seven major markets

This report is an effort to identify factors, which will be the driving force behind the diabetes devices and drugs market and sub-markets in the nextfew years. Thereport provides extensive analysis of the industry, current market trends, industry drivers and challenges for better understanding of the market structure. The report has segregated the diabetes devices and drugs industry in...

India with over 63 million diabetics represents the world’s second largest diabetes population after China. The Indian population that had faced under nutrition for a long time is now exposed to over nutrition and sedentary lifestyles. Coupled with a bad nutritional history and the fact that Indians are genetically more vulnerable to diabetes compared to other population groups,...

GlobalDatas pharmaceuticals report, Aleglitazar (Type 2 Diabetes) Analysis and Forecasts to 2020 provides Aleglitazar sales estimates for US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2017-2020). The report also includes information on Type 2...

GlobalDatas pharmaceuticals report, Avandia (Type 2 Diabetes) Analysis and Forecasts to 2020 provides Avandia sales estimates for US and EU5. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2002-2020). The report also includes information on Type 2 Diabetes...

Make an enquiry before buying this Report

Please fill the enquiry form below.

Full Name * :

Your Email * :

Job Title :

Phone No. * (Pls. Affix Country Code) :

Message :

Security Code * :

Choose License Type :

Single License User $2000
Multiple License User $4000

Do you wish to check sample of this report? Order a sample report.

Research Assistance

We will be happy to help you find what you need. Please call us or write to us: